Lyriko_WhitePaper_Graphic03-M

White Paper

Why Content Velocity
& Field Execution are Pharma’s Next AI Battleground

Lyriko_WhitePaper_Graphic03-M

What's inside?

Are you trying to understand where AI can truly generate value in the Pharma sector?

This white paper analyzes the two levers available today, without waiting for policy shifts or new R&D breakthroughs: content velocity and field execution. Discover how artificial intelligence can accelerate the compliant content lifecycle, boost the commercial effectiveness of field teams, and turn margin pressure into a concrete, measurable competitive advantage achievable within weeks.

Don't miss the chance to discover Pharma's next AI battleground!

Agenda

  • The competitive landscape: mature markets, patent cliffs, tariffs and M&A
  • Traditional levers and their limits (pricing policy, R&D, manufacturing)
  • Content Lifecycle and Commercial Effectiveness: the two levers available right now
  • The economic impact on EBITDA and revenue
  • The four structural bottlenecks 
  • AI as the answer: concrete opportunities and use cases
    • AI for Content Lifecycle: MLR pre-check, tagging, content generation
    • AI for Commercial Effectiveness: agentic field-force, next-best-action
  • Where to start: build, buy or co-develop, and how to choose the right path for each use case

Do you want our paper?